Exoproteome dynamics in Leishmania infantum

Journal of Proteomics

Volumn 84, Issue , 2013, Pages 106-118

  Santarém, Nuno ^a,b   Racine, Gina ^b   Silvestre, Ricardo ^a   Cordeiro da Silva, Anabela ^a,c   Ouellette, Marc ^b  

^a UNIVERSITY OF PORTO   (Portugal)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Exoproteome; GP63; Leishmania infantum; Promastigotes; Secreted proteins; Vesicles

Indexed keywords

EXOPROTEOME; PROTEOME; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; LEISHMANIA INFANTUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN ANALYSIS; PROTEIN METABOLISM;

LEISHMANIA INFANTUM; PROTEOME; PROTEOMICS; PROTOZOAN PROTEINS;

LEISHMANIA INFANTUM;

EID: 84877062495     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.03.012     Document Type: Article

References (67)

1. Control of the leishmaniases. World Health Organ Tech Rep Ser. 2010:xii-xiii, 1-186, back cover.
2. Mishra J., Saxena A., Singh S. Chemotherapy of leishmaniasis: past, present and future. Curr Med Chem 2007, 14:1153-1169.
3. Chappuis F., Sundar S., Hailu A., Ghalib H., Rijal S., Peeling R.W., et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?. Nat Rev Microbiol 2007, 5:873-882.
4. Santarem N., Silvestre R., Tavares J., Silva M., Cabral S., Maciel J., et al. Immune response regulation by Leishmania secreted and nonsecreted antigens. J Biomed Biotechnol 2007, 2007:85154.
5. Tonui W.K., Mejia J.S., Hochberg L., Mbow M.L., Ryan J.R., Chan A.S., et al. Immunization with Leishmania major exogenous antigens protects susceptible BALB/c mice against challenge infection with L. major. Infect Immun 2004, 72:5654-5661.
6. Corrales R.M., Sereno D., Mathieu-Daude F. Deciphering the Leishmania exoproteome: what we know and what we can learn. FEMS Immunol Med Microbiol 2010, 58:27-38.
7. Hassani K., Antoniak E., Jardim A., Olivier M. Temperature-induced protein secretion by Leishmania mexicana modulates macrophage signalling and function. PLoS One 2011, 6:e18724.
8. Silverman J.M., Clos J., de'Oliveira C.C., Shirvani O., Fang Y., Wang C., et al. An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages. J Cell Sci 2010, 123:842-852.
9. Geiger A., Hirtz C., Becue T., Bellard E., Centeno D., Gargani D., et al. Exocytosis and protein secretion in Trypanosoma. BMC Microbiol 2010, 10:20.
10. Trocoli Torrecilhas A.C., Tonelli R.R., Pavanelli W.R., da Silva J.S., Schumacher R.I., de Souza W., et al. Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response. Microbes Infect 2009, 11:29-39.
11. Cuervo P., De Jesus J.B., Saboia-Vahia L., Mendonca-Lima L., Domont G.B., Cupolillo E. Proteomic characterization of the released/secreted proteins of Leishmania (Viannia) braziliensis promastigotes. J Proteomics 2009, 73:79-92.
12. Silverman J.M., Chan S.K., Robinson D.P., Dwyer D.M., Nandan D., Foster L.J., et al. Proteomic analysis of the secretome of Leishmania donovani. Genome Biol 2008, 9:R35.
13. Chang K.P., Reed S.G., McGwire B.S., Soong L. Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity. Acta Trop 2003, 85:375-390.
14. Madureira P., Baptista M., Vieira M., Magalhaes V., Camelo A., Oliveira L., et al. Streptococcus agalactiae GAPDH is a virulence-associated immunomodulatory protein. J Immunol 2007, 178:1379-1387.
15. van Zandbergen G., Bollinger A., Wenzel A., Kamhawi S., Voll R., Klinger M., et al. Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum. Proc Natl Acad Sci U S A 2006, 103:13837-13842.
16. Moreira D., Santarem N., Loureiro I., Tavares J., Silva A.M., Amorim A.M., et al. Impact of continuous axenic cultivation in Leishmania infantum virulence. PLoS Negl Trop Dis 2012, 6:e1469.
17. Tonui W.K., Titus R.G. Cross-protection against Leishmania donovani but not L. Braziliensis caused by vaccination with L. major soluble promastigote exogenous antigens in BALB/c mice. Am J Trop Med Hyg 2007, 76:579-584.
18. Lemesre J.L., Holzmuller P., Goncalves R.B., Bourdoiseau G., Hugnet C., Cavaleyra M., et al. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial. Vaccine 2007, 25:4223-4234.
19. Moreira W., Leprohon P., Ouellette M. Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania. Cell Death Dis 2011, 2:e201.
20. Brun R., Schonenberger M. Cultivation and in vitro cloning or procyclic culture forms of Trypanosoma brucei in a semi-defined medium. Short communication. Acta Trop 1979, 36:289-292.
21. Santarem N., Cunha J., Silvestre R., Silva C., Moreira D., Ouellette M., et al. The impact of distinct culture media in Leishmania infantum biology and infectivity. Parasitology 2013, [submitted for publication].
22. Villalba J.D., Gomez C., Medel O., Sanchez V., Carrero J.C., Shibayama M., et al. Programmed cell death in Entamoeba histolytica induced by the aminoglycoside G418. Microbiology 2007, 153:3852-3863.
23. Paris C., Loiseau P.M., Bories C., Breard J. Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes. Antimicrob Agents Chemother 2004, 48:852-859.
24. Keller A., Nesvizhskii A.I., Kolker E., Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002, 74:5383-5392.
25. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75:4646-4658.
26. Kanehisa M., Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000, 28:27-30.
27. Aslett M., Aurrecoechea C., Berriman M., Brestelli J., Brunk B.P., Carrington M., et al. TriTrypDB: a functional genomic resource for the Trypanosomatidae. Nucleic Acids Res 2010, 38:D457-D462.
28. Horton P., Park K.J., Obayashi T., Fujita N., Harada H., Adams-Collier C.J., et al. WoLF PSORT: protein localization predictor. Nucleic Acids Res 2007, 35:W585-W587.
29. Bendtsen J.D., Jensen L.J., Blom N., Von Heijne G., Brunak S. Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng Des Sel 2004, 17:349-356.
30. Papadopoulou B., Roy G., Mourad W., Leblanc E., Ouellette M. Changes in folate and pterin metabolism after disruption of the Leishmania H locus short chain dehydrogenase gene. J Biol Chem 1994, 269:7310-7315.
31. Papadopoulou B., Roy G., Ouellette M. A novel antifolate resistance gene on the amplified H circle of Leishmania. EMBO J 1992, 11:3601-3608.
32. Foucher A.L., Papadopoulou B., Ouellette M. Prefractionation by digitonin extraction increases representation of the cytosolic and intracellular proteome of Leishmania infantum. J Proteome Res 2006, 5:1741-1750.
33. Gagnon D., Foucher A., Girard I., Ouellette M. Stage specific gene expression and cellular localization of two isoforms of the serine hydroxymethyltransferase in the protozoan parasite Leishmania. Mol Biochem Parasitol 2006, 150:63-71.
34. Neves B.M., Silvestre R., Resende M., Ouaissi A., Cunha J., Tavares J., et al. Activation of phosphatidylinositol 3-kinase/Akt and impairment of nuclear factor-kappaB: molecular mechanisms behind the arrested maturation/activation state of Leishmania infantum-infected dendritic cells. Am J Pathol 2010, 177:2898-2911.
35. Thery C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009, 9:581-593.
36. Saraiva E.M., Pinto-da-Silva L.H., Wanderley J.L., Bonomo A.C., Barcinski M.A., Moreira M.E. Flow cytometric assessment of Leishmania spp metacyclic differentiation: validation by morphological features and specific markers. Exp Parasitol 2005, 110:39-47.
37. Wanderley J.L., da Silva LH Pinto, Deolindo P., Soong L., Borges V.M., Prates D.B., et al. Cooperation between apoptotic and viable metacyclics enhances the pathogenesis of Leishmaniasis. PLoS One 2009, 4:e5733.
38. Bouvier J., Etges R.J., Bordier C. Identification and purification of membrane and soluble forms of the major surface protein of Leishmania promastigotes. J Biol Chem 1985, 260:15504-15509.
39. McGwire B.S., O'Connell W.A., Chang K.P., Engman D.M. Extracellular release of the glycosylphosphatidylinositol (GPI)-linked Leishmania surface metalloprotease, gp63, is independent of GPI phospholipolysis: implications for parasite virulence. J Biol Chem 2002, 277:8802-8809.
40. Contreras I., Gomez M.A., Nguyen O., Shio M.T., McMaster R.W., Olivier M. Leishmania-induced inactivation of the macrophage transcription factor AP-1 is mediated by the parasite metalloprotease GP63. PLoS Pathog 2010, 6:e1001148.
41. Wheeler R.J., Gluenz E., Gull K. The cell cycle of Leishmania: morphogenetic events and their implications for parasite biology. Mol Microbiol 2011, 79:647-662.
42. Cocucci E., Racchetti G., Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009, 19:43-51.
43. Wanderley J.L., Barcinski M.A. Apoptosis and apoptotic mimicry: the Leishmania connection. Cell Mol Life Sci 2010, 67:1653-1659.
44. Besteiro S., Williams R.A., Morrison L.S., Coombs G.H., Mottram J.C. Endosome sorting and autophagy are essential for differentiation and virulence of Leishmania major. J Biol Chem 2006, 281:11384-11396.
45. Pitzer F., Dantes A., Fuchs T., Baumeister W., Amsterdam A. Removal of proteasomes from the nucleus and their accumulation in apoptotic blebs during programmed cell death. FEBS Lett 1996, 394:47-50.
46. Kulichkova V.A., Mittenberg A.G., Ermolaeva Y.B., Tsimokha A.S., Volkova I.V., Evteeva I.N., et al. Specificity of the proteasome population secreted from cells into the culture medium. Dokl Biol Sci 2004, 399:503-506.
47. van Niel G., Porto-Carreiro I., Simoes S., Raposo G. Exosomes: a common pathway for a specialized function. J Biochem 2006, 140:13-21.
48. McConville M.J., Mullin K.A., Ilgoutz S.C., Teasdale R.D. Secretory pathway of trypanosomatid parasites. Microbiol Mol Biol Rev 2002, 66:122-154. [table of contents].
49. Stegmayer C., Kehlenbach A., Tournaviti S., Wegehingel S., Zehe C., Denny P., et al. Direct transport across the plasma membrane of mammalian cells of Leishmania HASPB as revealed by a CHO export mutant. J Cell Sci 2005, 118:517-527.
50. Duran J.M., Anjard C., Stefan C., Loomis W.F., Malhotra V. Unconventional secretion of Acb1 is mediated by autophagosomes. J Cell Biol 2010, 188:527-536.
51. Herman M., Perez-Morga D., Schtickzelle N., Michels P.A. Turnover of glycosomes during life-cycle differentiation of Trypanosoma brucei. Autophagy 2008, 4:294-308.
52. Michels P.A., Bringaud F., Herman M., Hannaert V. Metabolic functions of glycosomes in trypanosomatids. Biochim Biophys Acta 2006, 1763:1463-1477.
53. Marzella L., Ahlberg J., Glaumann H. Autophagy, heterophagy, microautophagy and crinophagy as the means for intracellular degradation. Virchows Arch B Cell Pathol Incl Mol Pathol 1981, 36:219-234.
54. Mathivanan S., Ji H., Simpson R.J. Exosomes: extracellular organelles important in intercellular communication. J Proteomics 2010, 73:1907-1920.
55. Johnstone R.M. Exosomes biological significance: a concise review. Blood Cells Mol Dis 2006, 36:315-321.
56. Nandan D., Yi T., Lopez M., Lai C., Reiner N.E. Leishmania EF-1alpha activates the Src homology 2 domain containing tyrosine phosphatase SHP-1 leading to macrophage deactivation. J Biol Chem 2002, 277:50190-50197.
57. Yao C. Major surface protease of trypanosomatids: one size fits all?. Infect Immun 2010, 78:22-31.
58. Joshi P.B., Kelly B.L., Kamhawi S., Sacks D.L., McMaster W.R. Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor. Mol Biochem Parasitol 2002, 120:33-40.
59. Gomez M.A., Contreras I., Halle M., Tremblay M.L., McMaster R.W., Olivier M. Leishmania GP63 alters host signaling through cleavage-activated protein tyrosine phosphatases. Sci Signal 2009, 2:ra58.
60. Denise H., Poot J., Jimenez M., Ambit A., Herrmann D.C., Vermeulen A.N., et al. Studies on the CPA cysteine peptidase in the Leishmania infantum genome strain JPCM5. BMC Mol Biol 2006, 7:42.
61. Swenerton R.K., Zhang S., Sajid M., Medzihradszky K.F., Craik C.S., Kelly B.L., et al. The oligopeptidase B of Leishmania regulates parasite enolase and immune evasion. J Biol Chem 2011, 286:429-440.
62. Julia V., Rassoulzadegan M., Glaichenhaus N. Resistance to Leishmania major induced by tolerance to a single antigen. Science 1996, 274:421-423.
63. Carvalho L.P., Passos S., Dutra W.O., Soto M., Alonso C., Gollob K.J., et al. Effect of LACK and KMP11 on IFN-gamma production by peripheral blood mononuclear cells from cutaneous and mucosal leishmaniasis patients. Scand J Immunol 2005, 61:337-342.
64. Vanegas G., Quinones W., Carrasco-Lopez C., Concepcion J.L., Albericio F., Avilan L. Enolase as a plasminogen binding protein in Leishmania mexicana. Parasitol Res 2007, 101:1511-1516.
65. Kolli B.K., Kostal J., Zaborina O., Chakrabarty A.M., Chang K.P. Leishmania-released nucleoside diphosphate kinase prevents ATP-mediated cytolysis of macrophages. Mol Biochem Parasitol 2008, 158:163-175.
66. Chopra P., Singh A., Koul A., Ramachandran S., Drlica K., Tyagi A.K., et al. Cytotoxic activity of nucleoside diphosphate kinase secreted from Mycobacterium tuberculosis. Eur J Biochem 2003, 270:625-634.
67. Sun J., Wang X., Lau A., Liao T.Y., Bucci C., Hmama Z. Mycobacterial nucleoside diphosphate kinase blocks phagosome maturation in murine RAW 264.7 macrophages. PLoS One 2010, 5:e8769.